Design
Review
Authors
Loading...
May support troponin I prioritization in myocardial injury; leaves open prospective validation against modern assays.
This review highlights the evolution of biochemical markers, particularly cardiac troponin I, as the preferred assay for detecting ischemic myocardial injury and assessing prognosis.
Joseph H. Keffer (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: